\-\ Texto\\:\\ \ \(0\)\
\-\ current\\ treatment\\ for\\ gbm\\ is\\ palliative\\ to\\ prolong\\ survival\\ without\\ therapy\\ patients\\ with\\ gbm\\ usually\\ die\\ with\\ 3\\ months\\.\\ patient\\ treated\\ with\\ optimal\\ therapy\\ \\,\\ including\\ surgical\\ resection\\,\\ radiation\\ therapy\\ and\\ chemotherapy\\ have\\ a\\ median\\ survival\\ of\\ one\\ year\\.\ \(0\)\
\-\ males\\ had\\ a\\ slight\\ preponderance\\ over\\ females\\ with\\ a\\ ratio\\ of\\ 5\\:1\\.\\ gbm\\ may\\ \\ manifest\\ at\\ any\\ age\\ with\\ peak\\ incidence\\ 45\\-70\\ yrs\\.\ \(0\)\
\-\ multiple\\ mr\\ images\\ taken\\ with\\ and\\ without\\ contrast\\ illustrates\\ a\\ cerebral\\ mass\\ located\\ within\\ corpus\\ callosum\\ with\\ surrounding\\ edema\\.\ \(0\)\
\-\ glioblastom\\ multiforme\\ \\(gbm\\)\ \(0\)\
\-\ gbm\ \(0\)\
\-\ cerebral\\ abscess\ \(11\)\
\-\ cns\\ lymphoma\ \(0\)\
\-\ demyelinating\\ processes\ \(0\)\
\-\ anaplastic\\ astrocytoma\ \(4\)\
\-\ metastasis\ \(206\)\
\-\ 51\\ year\\ old\\ with\\ symptoms\\ of\\ increased\\ intacranial\\ presure\\ for\\ approximately\\ 2\\ months\\.\\ \\ patient\\ complaineed\\ of\\ vomitting\\,\\ early\\ morning\\ headache\\,\\ seizures\\ and\\ personality\\ changes\\.\ \(0\)\
\-\ patient\\ underwent\\ surigal\\ excision\\ of\\ the\\ cerebral\\ mass\\ followed\\ by\\ post\\ operative\\ radiation\\ therapy\\.\\ \\ surgery\\ was\\ without\\ complications\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gbm\\:\\ 0\\.1696079969219106\ \(0\)\
\-\ survival\\:\\ 0\\.061495462004956224\ \(0\)\
\-\ therapy\\:\\ 0\\.061332638825251355\ \(0\)\
\-\ cerebral\\:\\ 0\\.05960630540464572\ \(0\)\
\-\ preponderance\\:\\ 0\\.05916455318098321\ \(0\)\
\-\ 45\\-70\\:\\ 0\\.05916455318098321\ \(0\)\
\-\ glioblastom\\:\\ 0\\.05916455318098321\ \(0\)\
\-\ intacranial\\:\\ 0\\.05916455318098321\ \(0\)\
\-\ complaineed\\:\\ 0\\.05916455318098321\ \(0\)\
\-\ surigal\\:\\ 0\\.05916455318098321\ \(0\)\
\-\ presure\\:\\ 0\\.05451255868058089\ \(0\)\
\-\ 5\\:1\\.\\:\\ 0\\.05179131634428449\ \(0\)\
\-\ prolong\\:\\ 0\\.04986056418017857\ \(0\)\
\-\ die\\:\\ 0\\.04520856967977625\ \(0\)\
\-\ vomitting\\:\\ 0\\.04371096195283525\ \(0\)\
\-\ personality\\:\\ 0\\.04371096195283525\ \(0\)\
\-\ optimal\\:\\ 0\\.04145275902249154\ \(0\)\
\-\ without\\:\\ 0\\.04051033220855356\ \(0\)\
\-\ manifest\\:\\ 0\\.03940321775033596\ \(0\)\
\-\ radiation\\:\\ 0\\.03764095636996424\ \(0\)\
\-\ yrs\\:\\ 0\\.036337725116136525\ \(0\)\
\-\ anaplastic\\:\\ 0\\.036117659191150016\ \(0\)\
\-\ demyelinating\\:\\ 0\\.035497704022485484\ \(0\)\
\-\ palliative\\:\\ 0\\.03493020477397499\ \(0\)\
\-\ illustrates\\:\\ 0\\.03475122324993364\ \(0\)\
\-\ multiforme\\:\\ 0\\.03332463639098282\ \(0\)\
\-\ median\\:\\ 0\\.03318333834267522\ \(0\)\
\-\ males\\:\\ 0\\.03304495386480451\ \(0\)\
\-\ peak\\:\\ 0\\.032646138962315906\ \(0\)\
\-\ females\\:\\ 0\\.03191325780818845\ \(0\)\
\-\ ratio\\:\\ 0\\.031798530067522\ \(0\)\
\-\ morning\\:\\ 0\\.031358279849496414\ \(0\)\
\-\ months\\:\\ 0\\.031328071069665335\ \(0\)\
\-\ 51\\:\\ 0\\.031148531235374904\ \(0\)\
\-\ processes\\:\\ 0\\.03104606497946357\ \(0\)\
\-\ operative\\:\\ 0\\.03094513962802371\ \(0\)\
\-\ callosum\\:\\ 0\\.029427527685390496\ \(0\)\
\-\ cns\\:\\ 0\\.02934810179514216\ \(0\)\
\-\ corpus\\:\\ 0\\.02825737072468729\ \(0\)\
\-\ slight\\:\\ 0\\.02697803945214602\ \(0\)\
\-\ current\\:\\ 0\\.026868013883181746\ \(0\)\
\-\ incidence\\:\\ 0\\.026293145127621386\ \(0\)\
\-\ seizures\\:\\ 0\\.02465674407693851\ \(0\)\
\-\ taken\\:\\ 0\\.02391439594577093\ \(0\)\
\-\ located\\:\\ 0\\.023605376224284977\ \(0\)\
\-\ excision\\:\\ 0\\.02353859548030398\ \(0\)\
\-\ complications\\:\\ 0\\.0227259919128326\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.022270806702505343\ \(0\)\
\-\ metastasis\\:\\ 0\\.021468102861073333\ \(0\)\
\-\ early\\:\\ 0\\.02097422127276804\ \(0\)\
\-\ including\\:\\ 0\\.02070750765767063\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.020556683121750772\ \(0\)\
\-\ headache\\:\\ 0\\.019697888842723475\ \(0\)\
\-\ underwent\\:\\ 0\\.019679168023343754\ \(0\)\
\-\ followed\\:\\ 0\\.019227354841468265\ \(0\)\
\-\ surrounding\\:\\ 0\\.018853458150099096\ \(0\)\
\-\ mr\\:\\ 0\\.018222815247962643\ \(0\)\
\-\ abscess\\:\\ 0\\.018133129155263536\ \(0\)\
\-\ any\\:\\ 0\\.018059295523975123\ \(0\)\
\-\ post\\:\\ 0\\.018059295523975123\ \(0\)\
\-\ resection\\:\\ 0\\.01788533996993435\ \(0\)\
\-\ approximately\\:\\ 0\\.017743743802386462\ \(0\)\
\-\ age\\:\\ 0\\.017455773996941655\ \(0\)\
\-\ usually\\:\\ 0\\.017415625864877576\ \(0\)\
\-\ patient\\:\\ 0\\.017246817401001098\ \(0\)\
\-\ treated\\:\\ 0\\.017166784134791002\ \(0\)\
\-\ changes\\:\\ 0\\.016436563598893023\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0163905948616744\ \(0\)\
\-\ edema\\:\\ 0\\.016220963016317386\ \(0\)\
\-\ mass\\:\\ 0\\.0159524967375512\ \(0\)\
\-\ one\\:\\ 0\\.015541821364500967\ \(0\)\
\-\ patients\\:\\ 0\\.01484278254608071\ \(0\)\
\-\ over\\:\\ 0\\.014601628121744715\ \(0\)\
\-\ symptoms\\:\\ 0\\.014293003200658651\ \(0\)\
\-\ increased\\:\\ 0\\.014030099206709098\ \(0\)\
\-\ surgery\\:\\ 0\\.013926168217183054\ \(0\)\
\-\ 3\\:\\ 0\\.013429365951050602\ \(0\)\
\-\ contrast\\:\\ 0\\.012837420716831579\ \(0\)\
\-\ year\\:\\ 0\\.012833627775475365\ \(0\)\
\-\ may\\:\\ 0\\.012579385026161904\ \(0\)\
\-\ have\\:\\ 0\\.012419047505805985\ \(0\)\
\-\ had\\:\\ 0\\.012374831001615492\ \(0\)\
\-\ 2\\:\\ 0\\.01234969460745333\ \(0\)\
\-\ multiple\\:\\ 0\\.012079234922679656\ \(0\)\
\-\ surgical\\:\\ 0\\.012055179666117138\ \(0\)\
\-\ treatment\\:\\ 0\\.011608167514099913\ \(0\)\
\-\ images\\:\\ 0\\.011001771086908417\ \(0\)\
\-\ within\\:\\ 0\\.0109404792509133\ \(0\)\
\-\ a\\:\\ 0\\.010646974545465806\ \(0\)\
\-\ for\\:\\ 0\\.009786686558962619\ \(0\)\
\-\ by\\:\\ 0\\.009549469149294462\ \(0\)\
\-\ at\\:\\ 0\\.007770222502225725\ \(0\)\
\-\ \\,\\:\\ 0\\.007267384309188923\ \(0\)\
\-\ was\\:\\ 0\\.006632735048414005\ \(0\)\
\-\ with\\:\\ 0\\.006282103414222267\ \(0\)\
\-\ old\\:\\ 0\\.00587204427424332\ \(0\)\
\-\ \\(\\:\\ 0\\.004848065276804433\ \(0\)\
\-\ \\)\\:\\ 0\\.004788843571230235\ \(0\)\
\-\ of\\:\\ 0\\.003909523516711021\ \(0\)\
\-\ is\\:\\ 0\\.0037737636133203063\ \(0\)\
\-\ and\\:\\ 0\\.003624342397292989\ \(0\)\
\-\ to\\:\\ 0\\.00286622891572474\ \(0\)\
\-\ \\.\\:\\ 0\\.0019060153609313437\ \(0\)\
\-\ the\\:\\ 0\\.0009278475483464818\ \(0\)\
